Getting FDA back on track: Editor’s Commentary

Regardless of the outcome of the elections, FDA is likely to have a new commissioner next year, one who will step into a leadership vacuum that is exhausting the agency’s supply of credibility and impairing its ability to promote public health.

Democratic Presidential Candidate Joe Biden’s transition team has been collecting names of potential FDA commissioners, and those anticipating a second term for President Donald Trump are polishing resumes, but the best starting point for determining who should be the agency’s next leader is to consider what that person must accomplish. ...